Investor’s Toolkit: Key Ratios for Assessing Rigel Pharmaceuticals (RIGL)’s Performance

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Rigel Pharmaceuticals (NASDAQ: RIGL) closed the day trading at $20.56 down -11.23% from the previous closing price of $23.16. In other words, the price has decreased by -$11.23 from its previous closing price. On the day, 0.58 million shares were traded. RIGL stock price reached its highest trading level at $23.275 during the session, while it also had its lowest trading level at $20.2601.

Ratios:

For a better understanding of RIGL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 33.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.96.

Piper Sandler Downgraded its Overweight to Neutral on June 08, 2022, whereas the target price for the stock was revised from $7 to $1.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 05 ’24 when Santos David A sold 8,918 shares for $1.14 per share. The transaction valued at 10,167 led to the insider holds 349,093 shares of the business.

Santos David A sold 5,601 shares of RIGL for $6,329 on Feb 02 ’24. The EVP, Chief Commercial Officer now owns 358,011 shares after completing the transaction at $1.13 per share. On Feb 05 ’24, another insider, Schorno Dean L, who serves as the EVP & Chief Financial Officer of the company, sold 7,027 shares for $1.14 each. As a result, the insider received 8,011 and left with 402,891 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RIGL now has a Market Capitalization of 407963840 and an Enterprise Value of 401260224. As of this moment, Rigel’s Price-to-Earnings (P/E) ratio for their current fiscal year is 94.92, and their Forward P/E ratio for the next fiscal year is 21.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.30. Its current Enterprise Value per Revenue stands at 2.55 whereas that against EBITDA is 35.447.

Stock Price History:

Over the past 52 weeks, RIGL has reached a high of $29.82, while it has fallen to a 52-week low of $7.48. The 50-Day Moving Average of the stock is 4.85%, while the 200-Day Moving Average is calculated to be 50.66%.

Shares Statistics:

Over the past 3-months, RIGL traded about 209.59K shares per day on average, while over the past 10 days, RIGL traded about 178000 shares per day. A total of 17.61M shares are outstanding, with a floating share count of 17.27M. Insiders hold about 1.98% of the company’s shares, while institutions hold 67.84% stake in the company. Shares short for RIGL as of 1732838400 were 470932 with a Short Ratio of 2.21, compared to 1730332800 on 661194. Therefore, it implies a Short% of Shares Outstanding of 470932 and a Short% of Float of 2.73.

Most Popular